German China
The IVD-seq project brings together a unique and complementary partnership of clinical IVD expertise from Fujirebio Europe and third generation sequencing based-omics solutions from OHMX.bio to develop a best-in-class IVD solution that completely operates from Belgium. (Deposit Photos )
Contemporary Solutions

OHMX.bio, Fujirebio Europe to Develop Clinical In Vitro Diagnostics Platform

Flanders Innovation & Entrepreneurship has awarded a 720K Euro research grant to OHMX.bio and Fujirebio Europe for developing a clinical in vitro diagnostics platform with third generation sequencing technologies. The project – IVD-seq aims to concentrate on a cost-efficient IVD modular solution for highly polymorphic regions initially and later on intends to expand the solution to other molecular diagnostic markers.

Read on